Medtronic (NYSE: MDT) — the world’s largest medical device company — will have to settle some doubts as it seeks to navigate through challenging economic times. That seemed to be the big message in a report out today from Needham & Co. analysts. They previewed what they expect from Medtronic’s Q1 results release on Aug. […]
Needham & Co.
Needham & Co. downgrades Medtronic, Zimmer Biomet shares
Needham & Co. Senior Research Analyst Mike Matson today downgraded his rating of Medtronic (NYSE:MDT) and Zimmer Biomet (NYSE:ZBH) shares to Hold, while Boston Scientific (NYSE:BSX) got an upgrade to Buy. MDT shares were down more than 1% to $97.98 apiece in morning trading, a day after Q4 earnings that missed The Street sent the […]
